Collectively, our data suggest that loss of Jak2 in smooth muscle cells confers protection against hypoxia‐induced pulmonary hypertension by attenuating pulmonary vascular remodelling and PASMC hyperplasia. This evidence concerns the gene JAK2 and pulmonary hypertension.